磷酸甘油酸激酶缺乏症中的肌病和帕金森病。
Myopathy and parkinsonism in phosphoglycerate kinase deficiency.
机构信息
Department of Neurology, Columbia University Medical Center, 3-313 Russ Berrie Medical Science Pavilion, 1150 St. Nicholas Avenue, New York, New York 10032, USA.
出版信息
Muscle Nerve. 2010 May;41(5):707-10. doi: 10.1002/mus.21612.
Abstract
A 25-year-old man with exertional myoglobinuria had no evidence of hemolytic anemia, but he had severe parkinsonism that was responsive to levodopa. Phosphoglycerate kinase (PGK) activity was markedly decreased in muscle, and molecular analysis of the PGK1 gene identified the p.T378P mutation that was recently reported in a patient with isolated myopathy. This case reinforces the concept that PGK deficiency is a clinically heterogeneous disorder and raises the question of a relationship between PGK deficiency and idiopathic juvenile Parkinson disease.
摘要
一位 25 岁的劳力性肌红蛋白尿患者没有溶血性贫血的证据，但他有严重的帕金森病，对左旋多巴有反应。肌肉中磷酸甘油酸激酶 (PGK) 活性明显降低，PGK1 基因突变的分子分析发现了最近报道的患有孤立性肌病的患者中的 p.T378P 突变。该病例进一步证实了 PGK 缺乏症是一种临床表现多样的疾病，并提出了 PGK 缺乏症与特发性青少年帕金森病之间的关系问题。
相似文献
1
Myopathy and parkinsonism in phosphoglycerate kinase deficiency.
Muscle Nerve. 2010 May;41(5):707-10. doi: 10.1002/mus.21612.
2
Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations.
Neuromuscul Disord. 2009 Mar;19(3):207-11. doi: 10.1016/j.nmd.2008.12.004. Epub 2009 Jan 20.
3
Phosphoglycerate kinase deficiency myopathy: biochemical and immunological studies of the mutant enzyme.
Muscle Nerve. 1984 Sep;7(7):542-51. doi: 10.1002/mus.880070705.
4
Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation.
Neurology. 2000 Mar 14;54(5):1188-90. doi: 10.1212/wnl.54.5.1188.
5
Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction.
Parkinsonism Relat Disord. 2019 Jul;64:319-323. doi: 10.1016/j.parkreldis.2019.04.004. Epub 2019 Apr 5.
6
Phosphoglycerate kinase deficiency: biochemical and molecular genetic studies in a new myopathic variant (PGK Alberta).
Neurology. 1993 Feb;43(2):387-91. doi: 10.1212/wnl.43.2.387.
7
Phosphoglycerate kinase deficiency: A nationwide multicenter retrospective study.
J Inherit Metab Dis. 2019 Sep;42(5):803-808. doi: 10.1002/jimd.12087. Epub 2019 Apr 8.
8
A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization.
Mol Genet Metab. 2012 Aug;106(4):455-61. doi: 10.1016/j.ymgme.2012.05.015. Epub 2012 May 30.
9
Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiency.
Neurology. 2018 Sep 11;91(11):e1077-e1082. doi: 10.1212/WNL.0000000000006165. Epub 2018 Aug 15.
10
A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina).
Ann Neurol. 1994 Mar;35(3):349-53. doi: 10.1002/ana.410350316.
引用本文的文献
1
Parkinson's disease and glucose metabolism impairment.
Transl Neurodegener. 2025 Feb 17;14(1):10. doi: 10.1186/s40035-025-00467-8.
2
Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage.
Sci Rep. 2025 Feb 5;15(1):4393. doi: 10.1038/s41598-025-88307-7.
3
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.
Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358.
4
Glycogen storage diseases.
Nat Rev Dis Primers. 2023 Sep 7;9(1):46. doi: 10.1038/s41572-023-00456-z.
5
A Mild Clinical Phenotype with Myopathic and Hemolytic Forms of Phosphoglycerate Kinase Deficiency (PGK Osaka): A Case Report and Literature Review.
Intern Med. 2022 Dec 1;61(23):3589-3594. doi: 10.2169/internalmedicine.9221-21. Epub 2022 May 7.
6
Cerebroventricular Injection of Pgk1 Attenuates MPTP-Induced Neuronal Toxicity in Dopaminergic Cells in Zebrafish Brain in a Glycolysis-Independent Manner.
Int J Mol Sci. 2022 Apr 8;23(8):4150. doi: 10.3390/ijms23084150.
7
Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases.
Molecules. 2022 Jan 30;27(3):951. doi: 10.3390/molecules27030951.
8
Glycolytic Metabolism, Brain Resilience, and Alzheimer's Disease.
Front Neurosci. 2021 Apr 28;15:662242. doi: 10.3389/fnins.2021.662242. eCollection 2021.
9
Towards Central Nervous System Involvement in Adults with Hereditary Myopathies.
J Neuromuscul Dis. 2020;7(4):367-393. doi: 10.3233/JND-200507.
10
Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases.
J Clin Invest. 2019 Oct 1;129(10):4539-4549. doi: 10.1172/JCI129987.
本文引用的文献
1
Mutations for Gaucher disease confer high susceptibility to Parkinson disease.
Arch Neurol. 2009 May;66(5):571-6. doi: 10.1001/archneurol.2009.72.
2
Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations.
Neuromuscul Disord. 2009 Mar;19(3):207-11. doi: 10.1016/j.nmd.2008.12.004. Epub 2009 Jan 20.
3
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
Neurology. 2007 Sep 18;69(12):1270-7. doi: 10.1212/01.wnl.0000276989.17578.02.
4
PGK deficiency.
Br J Haematol. 2007 Jan;136(1):3-11. doi: 10.1111/j.1365-2141.2006.06351.x.
5
Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain.
Br J Haematol. 2006 Feb;132(4):523-9. doi: 10.1111/j.1365-2141.2005.05882.x.
6
A novel missense mutation (1060G --> C) in the phosphoglycerate kinase gene in a Japanese boy with chronic haemolytic anaemia, developmental delay and rhabdomyolysis.
Br J Haematol. 2003 Sep;122(6):1009-13. doi: 10.1046/j.1365-2141.2003.04543.x.
7
Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation.
Neurology. 2000 Mar 14;54(5):1188-90. doi: 10.1212/wnl.54.5.1188.
8
9
Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred.
Br J Haematol. 1995 Sep;91(1):60-5. doi: 10.1111/j.1365-2141.1995.tb05245.x.
Zotero 插件